Why Demonstrated Value Is Not Enough Securing Access in a Constrained Pricing Environment

• Understanding how payer dynamics, account structures, and reimbursement pathways shape access outcomes beyond the strength of clinical and real-world evidence
• Navigating negotiation realities including contracting, channel dynamics, and policy constraints that influence pricing decisions even when value is clearly demonstrated
• Adapting market access strategy to focus on high impact moments that improve coverage and uptake, while balancing evidence generation with commercial and payer expectations

Speakers:

James Miteff

Vice President & Head of Market Access

Sumitomo Pharma America, Inc.